UHS (Universal Health Services) Risk Assessment

View and export this data going back to 1991. Start your Free Trial

What is Universal Health Services Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Universal Health Services is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of Universal Health Services's Risk Assessment

For the Medical Care Facilities subindustry, Universal Health Services's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Universal Health Services's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Universal Health Services's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Universal Health Services's Risk Assessment falls into.

Save Embed

Universal Health Services (NYSE:UHS) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Universal Health Services Risk Assessment Related Terms

Thank you for viewing the detailed overview of Universal Health Services's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Health Services Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Universal Health Services Inc (NYSE:UHS) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

0LJL:UK UHS:Germany UHS:Germany U1HS34:Brazil

Address

367 South Gulph Road, Universal Corporate Center, P.O. Box 61558, King Of Prussia, PA, USA, 19406-0958

Website

https://www.uhs.com

Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.

Executives

Maria Ruderman Singer	director	245 PARK AVENUE, NEW YORK NY 10167
Sussman Elliot J Md Mba	director
Warren J. Nimetz	director	1301 AVENUE OF THE AMERICAS, NEW YORK NY 10019
Nina Chen-langenmayr	director	211 N. 13TH STREET, 4TH FLOOR, PHILADELPHIA PA 19107
Eileen C. Mcdonnell	director	600 DRESHER ROAD, HORSHAM PA 19044
Matthew Jay Peterson	officer: Executive Vice President, UHS	2824 87TH TRAIL NORTH, MINNEAPOLIS MN 55443
Steve Filton	officer: Senior Vice President & CFO	367 SOUTH GULPH ROAD, KING PRUSSIA PA 19406
Marc D Miller	director, officer: President	367 SOUTH GULPH ROAD, KING OF PRUSSIA PA 19406
Lawrence S. Gibbs	director	599 LEXINGTON AVE # 20, NEW YORK NY 10022
Edward H Sim	officer: Executive Vice President	367 SOUTH GULPH ROAD, KING OF PRUSSIA PA 19406
Robert H Hotz	director	C/O MIKASA, 20633 S FORDYCE AVENUE, LONG BEACH CA 90810
Marvin G. Pember	officer: Senior Vice President	367 SOUTH GULPH ROAD, KING OF PRUSSIA PA 19406
Debra K Osteen	officer: Senior Vice President	367 SOUTH GULPH ROAD, KING PRUSSIA PA 19406
John H Herrell	director	367 SOUTH GULPH ROAD, KING PRUSSIA PA 19406
Anthony Pantaleoni	director	FULBRIGHT & JAWORSKI LLP, 666 FIFTH AVE, NEW YORK NY 10103